Myonex Unveils Enhanced Services for a Simplified Experience

[Horsham, PA, USA, March 31] – Myonex, a global leader in clinical trial supply and pharmaceutical commercial services, has announced new and expanded, integrated offerings to better address the real-world challenges facing the pharmaceutical and biotech industries.

Reducing Complexity with a Single, Trusted Partner

Managing multiple vendors can slow clinical trials, increase costs, and create inefficiencies. To streamline operations for its clients, Myonex is consolidating all expertise and capabilities under a single brand as of March 31. This move follows Myonex’s recent acquisitions including Creapharm (France), SaveWay Compounding Pharmacy (US), and Hubertus (Germany) – bringing together the strength to deliver a seamless, integrated experience for clients worldwide.

This transformation reflects client and industry feedback and reinforces Myonex’s commitment to being a comprehensive partner for clinical trials and commercial projects. The newly expanded services include:

• Expanded Clinical Services – Providing the flexibility the industry needs for trial execution.
• Tailored Pharmaceutical Commercial Services – Helping companies and products reach the market.
• Expert Consulting Services – Offering strategic insights and guidance at critical moments.

With these enhancements, Myonex is more committed than ever to enabling faster, more flexible trial execution, patient-centric solutions, and optimized supply strategies.

A Mission Built on Confidence and Innovation

James Lovett, CEO of Myonex, emphasized, “Our experienced and client-focused colleagues deliver confidence to clients – meeting our mission of ensuring patients receive life-changing medicines through agile, innovative services and solutions.”

This mission underscores Myonex’s dedication to optimizing trial execution, expanding patient access, and simplifying supply chain complexities—always with the client and patient in mind.

Discover the Newly Enhanced Myonex

In tandem with its expanded services, Myonex has launched a newly updated website, making it easier than ever to explore solutions and connect with experts.

Media Contact

• USA: Renea Miller, Director, Marketing | [email protected]
• EU: Sophie Lafon-Rouquier, Associate Director, Marketing | [email protected]

About Myonex
Myonex is an industry leader in global clinical trial supply and pharmaceutical commercial services. Our suite of integrable services and solutions helps pharmaceutical, biotech, and CRO partners advance medicine by reducing time, costs, and complexity. With locations in the US, Germany, UK, and France, our comprehensive, client-focused approach, coupled with expert project management, ensures seamless execution across regions, optimizes supply chain efficiency, and adapts to evolving trial or project needs while delivering quality, flexibility, and global scale.